RESUMO
BACKGROUND: Complementary and Alternative Medication (CAM) is commonly used among women with breast cancer to improve their quality of life (QoL). However, few studies examine the prevalence of CAM and its' relation to the patients' QoL among women with breast cancer. METHODS: A cross-sectional study was conducted among 95 women with breast cancer at a tertiary hospital in Saudi Arabia. The outcome measure of interest was the QoL. The correlation was used to assess the association between CAM use and QoL. Bivariate and multivariate analyses were used to examine the factors that affect the use of CAM. The data was analysed using Statistical Package for the Social Sciences (SPSS) version 24.0. RESULTS: CAM use was reported by 81.1% of the study participants. The most commonly used CAM therapy was spiritual therapy 70.5%, followed by honey 36.8%, olive oil 24.2% and 23.2% herbal therapy. We found that those who were undergoing cancer treatment had a significantly higher percentage of CAM usage as compared to those not undergoing cancer therapy (72.6% vs. 8.4%, P=0.008). With regards to QoL, there was a statistically significant difference between CAM users and non-CAM users in global health status (73.2% vs. 64.8%, P = 0.049). CONCLUSIONS: CAM therapy was commonly used among women in our study sample which was correlated with higher overall global QoL. As CAM is widely used, health care providers may need to discuss the use of CAM with breast cancer women and be up to date on the benefits and risk of CAM use through well-equipped training programs and workshops.
RESUMO
BACKGROUND: Processing health-related data is challenging for patients. It is believed that low education level and low socioeconomic status are associated with prescription label misunderstanding, which may lead to poor clinical outcomes, increased adverse drug reactions, and increased health costs. OBJECTIVES: The aim of this study was to gain a better insight into the current understanding of prescription drug labels, and to determine the main factors affecting patients' understanding of prescription labels. METHOD: A total of 511 adult participants in 4 major hospitals in Riyadh were interviewed. The primary outcome was patient understanding of prescription labels for 5 commonly prescribed medications. Prescription label understanding was assessed using a prespecified structured interview protocol. Participants with less than a 6th-grade education level and monthly income less than 10,000 Saudi Riyal were considered to have a low education level and low monthly income, respectively. Logistic regression analysis was used to examine the cross-sectional association of socioeconomic factors with the participants' understanding of the medication label. RESULTS: The prevalence of poor understanding of the medication labels was 38.6% among the participants. Out of those participants with poor understanding, 27.9% incorrectly understood at least 4 of the 5 labels. The degree of misunderstanding significantly worsened for older participants (P-value = 0.004), male (P-value < 0.001), with low education level (P-value = 0.002), and low monthly income (P-value = 0.012). The most common features misunderstood were duration of treatment (38.9%) and storage instructions (29.5%). CONCLUSIONS: Prescription label misunderstanding is common among participants. More efforts should be made to improve patients' understanding by reducing the ambiguity of the prescription labels.
